ARS Pharma intends to submit this repeat-dose NAC study data to the FDA as part of its response to the CRL early in the second quarter of 2024. The randomized, crossover pharmacokinetic (PK ...

The risk level is the FDA's second most severe level as it could cause "temporary or medically reversible adverse health consequences." The bottles contain the "presence" of nitrosamine drug ...

FDA-approved sNDA adds a simplified, IV NAC dosing regimen to the product prescribing information. New IV NAC dosing regimen is both safe and effective. New dosing regimen aims to minimize ...

From stopping embolisms to other blockages, the future with NAC is only just beginning. The researchers are hoping to conduct ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

"This FDA approval is a significant step forward in the treatment of acetaminophen overdose," said Rick Dart, MD, PhD, Director at the Rocky Mountain Poison and Drug Center. "By streamlining the ...